末梢血管ステント市場：セグメント別規模、シェア、法規制、償還、インターベンション、2036年までの予測

末梢血管ステントは、血流の狭窄を防ぐために末梢血管に挿入する拡張可能な有孔チューブです。人口の高齢化、先進諸国における疾患の高い有病率、新しく改良された診断方法の開発が、血管形成術やステント留置術などの低侵襲技術を用いた治療率の上昇に寄与しています。末梢動脈疾患（PAD）の治療に用いられる低侵襲技術には、バルーン血管形成術、ステント留置術、アテレクトミーなどがあります。これらの治療法は回復に要する時間や感染症や出血のリスクを軽減することができ、臨床で頻繁に用いられています。バルーン血管形成術とステント留置術は、侵襲的な動脈バイパス手術に代わって、PAD患者の治療の第一選択となっています。これらの低侵襲的治療法は、脚や腎臓、頸動脈など、体のさまざまな部位で狭窄したり閉塞したりした動脈を開くために使用されます。末梢ステント留置術では、閉塞した末梢動脈にステントを挿入して血管を広げ、正常な血流を確保します。弾性反動や新生内膜過形成など、バルーン血管形成術に伴う問題があるため、ステント留置術が望ましい選択肢となっています。

当レポートは、世界の末梢血管ステント市場について詳細に考察し、市場における競合情勢、SWOT分析、2036年までの市場予測、地域、国別の動向などを提供しています。

目次

現在上市されている末梢血管ステントと競合情勢

• 主要な業界動向の洞察
• 末梢血管ステントのセグメント別総市場収益と2015年～2036年の市場展望
• セグメント別の手技総数（インターベンション総数）、台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 末梢血管ステント市場のSWOT分析
• 末梢血管ステント市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

Peripheral Vascular Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

A peripheral vascular stent is an expandable perforated tube that is inserted into a peripheral vessel to prevent blood flow constriction. The aging population, the high prevalence of the disease in developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates using minimally invasive techniques, such as angioplasty and stenting. Minimally invasive techniques used to treat peripheral artery disease (PAD) include balloon angioplasty, stenting, and atherectomy. These interventions have reduced recovery times and the risk of infection and bleeding, and are frequently used in clinical practice. Balloon angioplasty and stenting have replaced invasive artery bypass surgery as the first line of treatment for patients with PAD. These minimally invasive interventions are used to open narrowed and occluded arteries in many different parts of the body, including in the legs, kidneys, as well as carotid arteries. Peripheral stenting involves inserting a stent into the blocked peripheral artery to widen it and allow for normal blood flow through the vessel. Problems associated with balloon angioplasty, such as elastic recoil and neointimal hyperplasia, make stenting the preferable option.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Peripheral Vascular Stents market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Peripheral Vascular Stents market revenue by segment and market outlooks from 2015-2036.
• Granular data on total interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Peripheral Vascular Stents market.
• Competitive dynamics insights and trends provided Peripheral Vascular Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: W.L. Gore & Associates Inc ,Boston Scientific Corp, CR Bard Inc ,Cook Medical Inc ,Abbott Laboratories ,Medtronic Plc, Getinge AB,Cordis Corp,Terumo Corp,Biotronik SE & Co KG,Kyoto Medical Planning Co Ltd

Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Peripheral Vascular Stents marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Peripheral Vascular Stents market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Peripheral Vascular Stents market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Peripheral Vascular Stents market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.